Effectiveness of Chinese Handwriting Intervention Program for Children With ASD
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · May 2, 2023
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. first or second grader
- • 2. reported problems with poor handwriting legibility or performed less readable handwriting as claimed by their school teachers or caregivers
- • 3. score at most 33 scores in overall legibility dimension or at-least 45 incorrect strokes in Chinese Handwriting Legibility Assessment for Children (CHLAC)
- • 4. previously diagnosed with ASD
- • 5. and score at least seven scores in Autism Behavior Checklist Taiwan Version (ABC-T) will be included in this study.
- Exclusion Criteria:
- • 1. any physical disability affecting the upper limb
- • 2. any hearing or visual impairment
- • 3. intelligence quotient below 70 or previously diagnosed with intellectual disability
- • 4. unable to follow the evaluation instruction.
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported